Table 2.
Spearman’s correlation coefficients between GDF-15 and clinical and biochemical parameters
| Spearman correlation | ||
|---|---|---|
| Coefficient | P | |
| Age, years | 0.267 | < 0.001 |
| Male, n (%) | − 0.025 | 0.133 |
| BMI (kg/m2) | − 0.024 | 0.100 |
| Current smokers, n (%) | − 0.025 | 0.127 |
| Hypertension, n (%) | 0.079 | < 0.001 |
| Hyperlipidemia, n (%) | 0.053 | 0.031 |
| Diabetes mellitus, n (%) | 0.137 | < 0.001 |
| Previous MI, n (%) | 0.064 | < 0.001 |
| Previous PCI/CABG, n (%) | 0.096 | < 0.001 |
| TC (mmol/L) | 0.017 | 0.315 |
| HDL-C (mmol/L) | 0.007 | 0.656 |
| LDL-C (mmol/L) | 0.014 | 0.403 |
| TG (mmol/L) | − 0.022 | 0.192 |
| Medications | ||
| Aspirin, n (%) | − 0.057 | 0.001 |
| ACEI, n (%) | 0.025 | 0.134 |
| β-blocker, n (%) | − 0.031 | 0.050 |
| Statins, n (%) | − 0.032 | 0.055 |